Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Summers

Showing results (121-130 of 139) with videos related to

Pageof 14
Sort By:
Fertility and Sterility|July 7, 2015
Antimüllerian hormone as a predictor of good-quality supernumerary blastocyst cryopreservation among women with levels <1 ng/mL versus 1-4 ng/mLShahryar K Kavoussi, Kate C Odenwald, Lynn M Boehnlein, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1996
Properties of ABT-299, a prodrug of A-85783, a highly potent platelet activating factor receptor antagonistD H Albert, R G Conway, T J Magoc, et al.
Clinical and Experimental Pharmacology & Physiology|December 1, 2011
Early origins of heart disease: low birth weight and determinants of cardiomyocyte endowmentK J Botting, K C W Wang, M Padhee, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 31, 2018
Identifying opportunities to advance practice at a large academic medical center using the ASHP Ambulatory Care Self-Assessment ToolAmber Lanae Martirosov, Angela Michael, Melissa McCarty, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1995
ABT-299, a potent antagonist of platelet activating factorJ B Summers, D H Albert, S K Davidsen, et al.
Journal of Medicinal Chemistry|October 1, 1988
Structure-activity analysis of a class of orally active hydroxamic acid inhibitors of leukotriene biosynthesisJ B Summers, B P Gunn, J G Martin, et al.
Journal of Medicinal Chemistry|January 1, 1988
Orally active hydroxamic acid inhibitors of leukotriene biosynthesisJ B Summers, B P Gunn, J G Martin, et al.
ACS Chemical Biology|March 10, 2020
Covalent-Fragment Screening of BRD4 Identifies a Ligandable Site Orthogonal to the Acetyl-Lysine Binding SitesMichael D Olp, Daniel J Sprague, Christopher J Goetz, et al.
European Journal of Pharmacology|April 23, 1997
Pharmacology of ABT-491, a highly potent platelet-activating factor receptor antagonistD H Albert, T J Magoc, P Tapang, et al.
Open Forum Infectious Diseases|July 10, 2024
Therapeutic Myths in Solid Organ Transplantation Infectious DiseasesKellie J Goodlet, Erin K McCreary, Michael D Nailor, et al.
Pageof 14

Showing results (121-130 of 139) with videos related to

Sort By:
Pageof 14
Fertility and Sterility|July 7, 2015
Antimüllerian hormone as a predictor of good-quality supernumerary blastocyst cryopreservation among women with levels <1 ng/mL versus 1-4 ng/mLShahryar K Kavoussi, Kate C Odenwald, Lynn M Boehnlein, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1996
Properties of ABT-299, a prodrug of A-85783, a highly potent platelet activating factor receptor antagonistD H Albert, R G Conway, T J Magoc, et al.
Clinical and Experimental Pharmacology & Physiology|December 1, 2011
Early origins of heart disease: low birth weight and determinants of cardiomyocyte endowmentK J Botting, K C W Wang, M Padhee, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 31, 2018
Identifying opportunities to advance practice at a large academic medical center using the ASHP Ambulatory Care Self-Assessment ToolAmber Lanae Martirosov, Angela Michael, Melissa McCarty, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1995
ABT-299, a potent antagonist of platelet activating factorJ B Summers, D H Albert, S K Davidsen, et al.
Journal of Medicinal Chemistry|October 1, 1988
Structure-activity analysis of a class of orally active hydroxamic acid inhibitors of leukotriene biosynthesisJ B Summers, B P Gunn, J G Martin, et al.
Journal of Medicinal Chemistry|January 1, 1988
Orally active hydroxamic acid inhibitors of leukotriene biosynthesisJ B Summers, B P Gunn, J G Martin, et al.
ACS Chemical Biology|March 10, 2020
Covalent-Fragment Screening of BRD4 Identifies a Ligandable Site Orthogonal to the Acetyl-Lysine Binding SitesMichael D Olp, Daniel J Sprague, Christopher J Goetz, et al.
European Journal of Pharmacology|April 23, 1997
Pharmacology of ABT-491, a highly potent platelet-activating factor receptor antagonistD H Albert, T J Magoc, P Tapang, et al.
Open Forum Infectious Diseases|July 10, 2024
Therapeutic Myths in Solid Organ Transplantation Infectious DiseasesKellie J Goodlet, Erin K McCreary, Michael D Nailor, et al.
Pageof 14